Venugopal Gunda

Venugopal Gunda

UNVERIFIED PROFILE

Are you Venugopal Gunda?   Register this Author

Register author
Venugopal Gunda

Venugopal Gunda

Publications by authors named "Venugopal Gunda"

Are you Venugopal Gunda?   Register this Author

18Publications

-Reads

Hypoxia-Induced Metabolomic Alterations in Pancreatic Cancer Cells.

Methods Mol Biol 2018 ;1742:95-105

The Eppley Institute for Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE, USA.

View Article
January 2018

MUC1-Mediated Metabolic Alterations Regulate Response to Radiotherapy in Pancreatic Cancer.

Clin Cancer Res 2017 Oct 18;23(19):5881-5891. Epub 2017 Jul 18.

The Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska.

View Article
October 2017

Glucose Limitation Alters Glutamine Metabolism in MUC1-Overexpressing Pancreatic Cancer Cells.

J Proteome Res 2017 Oct 30;16(10):3536-3546. Epub 2017 Aug 30.

Department of Chemistry, and ‡Nebraska Center for Integrated Biomolecular Communication, University of Nebraska-Lincoln , Lincoln, Nebraska 68588, United States.

View Article
October 2017

Lipid Synthesis Facilitates Gemcitabine Resistance through Endoplasmic Reticulum Stress in Pancreatic Cancer.

Cancer Res 2017 10 15;77(20):5503-5517. Epub 2017 Aug 15.

Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska.

View Article
October 2017

MUC1 facilitates metabolomic reprogramming in triple-negative breast cancer.

PLoS One 2017 2;12(5):e0176820. Epub 2017 May 2.

The Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska, United States of America.

View Article
September 2017

GOT1-mediated anaplerotic glutamine metabolism regulates chronic acidosis stress in pancreatic cancer cells.

Cancer Lett 2017 08 26;400:37-46. Epub 2017 Apr 26.

The Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE, USA; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, USA; Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA; Department of Genetics Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, NE, USA. Electronic address:

View Article
August 2017

Validation of Metabolic Alterations in Microscale Cell Culture Lysates Using Hydrophilic Interaction Liquid Chromatography (HILIC)-Tandem Mass Spectrometry-Based Metabolomics.

PLoS One 2016 27;11(4):e0154416. Epub 2016 Apr 27.

Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska, United States of America.

View Article
March 2017

Silibinin-mediated metabolic reprogramming attenuates pancreatic cancer-induced cachexia and tumor growth.

Oncotarget 2015 Dec;6(38):41146-61

The Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska 68198, USA.

View Article
December 2015

MUC16-mediated activation of mTOR and c-Myc reprograms pancreatic cancer metabolism.

Oncotarget 2015 Aug;6(22):19118-31

The Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska, USA.

View Article
August 2015

Extra cellular matrix derived metabolite regulates angiogenesis by FasL mediated apoptosis.

PLoS One 2013 4;8(12):e80555. Epub 2013 Dec 4.

Irma Lerma Rangel College of Pharmacy, Texas A&M Health Science Center, Kingsville, Texas, United States of America.

View Article
September 2014

Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia.

Cancer Metab 2014 1;2:18. Epub 2014 Sep 1.

The Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198, USA ; Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE 68198, USA ; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE 68198, USA ; Department of Genetic Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, NE 68198, USA.

View Article
September 2014

Developments in purification methods for obtaining and evaluation of collagen derived endogenous angioinhibitors.

Protein Expr Purif 2014 Feb 9;94:46-52. Epub 2013 Nov 9.

Cell Signaling Laboratory, Center for Cancer and Metabolism, Bioscience Division, SRI International, Menlo Park, CA 94025, USA. Electronic address:

View Article
February 2014

Inhibition of elastin peptide-mediated angiogenic signaling mechanism(s) in choroidal endothelial cells by the α6(IV)NC1 collagen fragment.

Invest Ophthalmol Vis Sci 2013 Dec 17;54(13):7828-35. Epub 2013 Dec 17.

Cell Signaling, Retinal & Tumor Angiogenesis Laboratory, Boys Town National Research Hospital, Omaha, Nebraska.

View Article
December 2013

Regulation of Tumor Angiogenesis and Choroidal Neovascularization by Endogenous Angioinhibitors.

J Cancer Sci Ther 2013 Jul;5(12):417-426

Cell Signaling Laboratory, Bioscience Division, Center for Cancer and Metabolism, Stanford Research Institute (SRI) International, Menlo Park, CA 94025, USA.

View Article
July 2013

L-arginine mediated renaturation enhances yield of human, α6 Type IV collagen non-collagenous domain from bacterial inclusion bodies.

Protein Pept Lett 2012 Oct;19(10):1112-21

Cell Signaling, Retinal and Tumor Angiogenesis Laboratory, Department of Genetics, Boys Town National Research Hospital, Omaha, NE 68131, USA.

View Article
October 2012